Transcatheter arterial micro-embolization (TAME) using imipenem/cilastatin sodium for chronic musculoskeletal pain chronic musculoskeletal pain resistant to conservative treatment
- Conditions
- lateral humeral epicondylitis, medial humeral epicondylitis, shoulder periarthritis, intractable pain after artificial joint surgery, knee osteoarthritis, hip osteoarthritis
- Registration Number
- JPRN-UMIN000031797
- Lead Sponsor
- Wakayama medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Not provided
1)Surgical candidate 2)Patients with major depression 3)Patients with uncontrollable diabetic mellitus 4)Patients without possibility of going to hospital and follow up for 6 months. 5)Patient who was decided not to be appropriate for this trial by physician 6)Patients with a history of hypersensitivity or shock to antibiotics of imipenem . cilastatin, carbapenem, penicillin or cephem 7)Patients who are receiving sodium valproate 8)Patients with a history of severe thrombotic symptoms such as myocardial infarction and cerebral infarction 9)Patients diagnosed as anti-phospholipid antibody syndrome 10)Patients performing antiplatelet drugs or anticoagulation therapy 11)Patients diagnosed as collagen diseases such as rheumatoid arthritis and polymyalgia rheumatic 12)Pregnant patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical efficacy 1) Numerical Rating Scale (NRS) in 6 months after the procedure 2) Quality of life (QOL) in 6 months after the procedure
- Secondary Outcome Measures
Name Time Method Incidence of adverse events